Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 3/20 | 0.69 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.69 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CASR | P41180 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7615107 | 1.00 | ANPEP (0.69) | ANPEPENPEPGRM4KMT2AALDH1A1 | |
| SCHEMBL7620694 | 1.00 | ANPEP (0.69) | ANPEPENPEPGRM4KMT2AALDH1A1 | |
| SCHEMBL7616448 | 0.87 | ANPEP (0.73) | ANPEPENPEPGRM4KMT2AALDH1A1 | |
| SCHEMBL7573702 | 0.87 | ANPEP (0.73) | ANPEPENPEPGRM4KMT2AALDH1A1 | |
| SCHEMBL7612693 | 0.87 | ANPEP (0.73) | ANPEPENPEPGRM4KMT2AALDH1A1 | |
| SCHEMBL22691505 | 0.85 | ANPEP (0.71) | ANPEPENPEPGRM4CA1CA2 | |
| SCHEMBL22690103 | 0.85 | ANPEP (0.71) | ANPEPENPEPGRM4CA1CA2 | |
| SCHEMBL21436044 | 0.83 | LOXL2 (0.51) | ANPEPENPEPALDH1A1CASR | |
| SCHEMBL28555690 | 0.82 | ANPEP (0.53) | ANPEPENPEPGRM4KMT2AALDH1A1 | |
| SCHEMBL6838300 | 0.82 | ANPEP (0.53) | ANPEPENPEPGRM4KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020183249-A1 | Method of identifying inhibitors of CDC25 | TAYLOR NEIL R (AU) | 2002-12-05 | — | — | US | claimed |
| US-20020183249-A1 | Method of identifying inhibitors of CDC25 | TAYLOR NEIL R (AU) | 2002-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183249-A1 | Method of identifying inhibitors of CDC25 | CDC25C, CDC25A, CDC25B | ANPEP 521/4885ENPEP 553/4885GRM4 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.